Pricing Log in Create free account
Friday 6 November 2026 Export AXSM’s income statement to Excel — free account

Axsome Therapeutics, Inc.

AXSM Healthcare Biotechnology

Axsome Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $638.5 million, up 65.5% from fiscal 2024.

Revenue
+51.9%
EPS
+73.9%
Free cash flow
−1,078.3%
Total debt
+4.04%

Quarter to September 2026, against a year earlier

132.13 2.33 +1.80%
Market cap
$6.8B
P/E
0.0×
Fwd P/E
−49.2×
Dividend yield
—
F-score
5/9
Altman Z
6.91
Beneish M
−2.53
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Axsome Therapeutics, Inc. (AXSM) Current ratio

Alert me on Current ratio

Axsome Therapeutics, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 1.4×, down 0.1× from fiscal 2025 (1.6×). Over the past ten years it has ranged from 1.4× (fiscal 2018) to 18.6× (fiscal 2015); the current reading is higher than 18% of that period. That is below the Biotechnology industry median of 4.9× and below the Healthcare sector median of 3.1×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 1.6× (26.25%)
FY2024 2.1× (41.95%)
FY2023 3.6× 42.76%
FY2022 2.5× (32.18%)
FY2021 3.8× (52.23%)
FY2020 7.9× (12.73%)
FY2019 9.0× 539.90%
FY2018 1.4× (51.51%)
FY2017 2.9× (45.29%)
FY2016 5.3× (71.56%)

Quarterly newest first

Period Current ratio Change
Sep 2026 1.4× (0.30%)
Jun 2026 1.4× 2.46%
Mar 2026 1.4× (10.49%)
Dec 2025 1.6× (0.92%)
40 more quarters

Against its own ten years

Low 1.4× High 18.6×
Ten-year median 3.6×
Current reading's percentile 18

Current ratio against peers

Company Current ratio
ORKA Oruka Therapeutics, Inc. compare 38.5×
BLTE Belite Bio, Inc. Sponsored ADR compare 33.6×
PRAX Praxis Precision Medicines, Inc. compare 15.7×
IONS Ionis Pharmaceuticals, Inc. compare 7.9×
ABVX Abivax SA Sponsored ADR compare 6.0×
RYTM Rhythm Pharmaceuticals, Inc. compare 2.8×
MIRM Mirum Pharmaceuticals, Inc. compare 2.1×
AXSM Axsome Therapeutics, Inc. 1.4×
LGND Ligand Pharmaceuticals Incorporated compare 1.2×
Biotechnology industry median 4.9×
Healthcare sector median 3.1×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on AXSM